WHO ICTRP trial
Clinical trial to shortening the treatment for pulmonary tuberculosis with…
EUCTR2015-003446-45-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2015-003446-45-ES |
|---|---|
| Public title | Clinical trial to shortening the treatment for pulmonary tuberculosis with rifapentin containing regimen. |
| Scientific title | Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase 3 clinical trial - TBTCS31 |
| Primary sponsor | Unidad de investigación en Tuberculosis de Barcelona |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Hong Kong;Kenya;Spain;Peru;Uganda;South Africa;Vietnam;United States |
| Conditions | Pulmonary tuberculosis;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] |
| Interventions | Trade Name: Priftin Product Name: RIFAPENTINE Pharmaceutical Form: Tablet INN or Proposed INN: RIFAPENTINE CAS Number: 61379-65-5 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 150- Trade Name: Rifadin… |
| Registration date | Oct 15, 2015 |
| Target size | 2500 |
| Secondary IDs | TBTCS31/A5349 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: